Skip to search formSkip to main contentSkip to account menu

S 15261

Known as: S-15261, S15261 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Aim:  S 15261 is a novel oral antihyperglycaemic drug with both insulin secretagogue and insulin‐sensitizing effects. The study… 
2004
2004
SummaryA new oral agent, S15261 (the L-isomer of 3- [2- [2- [4- [2- [α-fluorenyl acetyl amino ethyl] benzoyloxy] ethyl amino] 1… 
2000
2000
S15261, a compound developed for the oral treatment of type II diabetes, is cleaved by esterases to the fragments Y415 and S15511… 
2000
2000
This meeting focused on the recent developments in the fields of adipogensis and insulin resistance. In particular, the molecular… 
1998
1998
The new compound S 15261 (CAS 159978-02-6) is the I-isomer of 3-[2-[2-[4-[2-(alpha-Fluorenylacetylamino)ethyl]benzoyloxy]ethylam… 
1997
1997
A histological study has been conducted on pancreata from insulin resistant sand rats treated with S15261. As previously shown…